Samantha Eisman

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Atopic Dermatitis

Replacement Therapy

Top Venues

The Australasian journal of dermatology

Pediatric dermatology

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Bennett, Rodney Daniel Sinclair, Samantha Eisman
Upadacitinib treatment in patients with moderate to severe atopic dermatitis: A retrospective single-centre Australian review of 14 patients post phase 3 clinical trial. The Australasian journal of dermatology 64 (1) (2023)
Michaela Bennett, Rodney Daniel Sinclair, Samantha Eisman
Upadacitinib treatment in patients with moderate to severe atopic dermatitis: A retrospective single-centre Australian review of 14 patients post phase 3 clinical trial. The Australasian journal of dermatology (2023)
Michaela Bennett, Rodney Daniel Sinclair, Samantha Eisman
Upadacitinib treatment in patients with moderate to severe atopic dermatitis: A retrospective single-centre Australian review of 14 patients post phase 3 clinical trial. The Australasian journal of dermatology 64 (1) (2023)
Anthony Moussa, Lella Asfour, Samantha Eisman, Bevin Bhoyrul, Rodney Daniel Sinclair
Successful treatment of folliculitis decalvans with baricitinib: A case series. The Australasian journal of dermatology 63 (2) (2022)
Blake Phillip Mumford, Samantha Eisman, Leona Yip
Acquired causes of eyebrow and eyelash loss: A review and approach to diagnosis and treatment. The Australasian journal of dermatology (2022)
Samantha Eisman, Rodney Daniel Sinclair
Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata. Expert opinion on investigational drugs (2021)
Rebekka Jerjen, Nekma Meah, Lara Trindade de Carvalho, Dmitri Wall, Samantha Eisman, Rodney Daniel Sinclair
Treatment of alopecia areata in pre-adolescent children with oral tofacitinib: A retrospective study. Pediatric dermatology 38 (1) (2020)